Uncategorized

Generic of Novo’s GLP-1 arrives in Canada, a ‘test case for the world’

Published

5 days ago

on

Analysts will be watching as a generic version of semaglutide—marketed by Novo Nordisk as Wegovy for weight loss—launches in Canada as a test case for future price erosion in the U.S.

Related Topics:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version